article thumbnail

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. The FDA still has to make a decision on whether to officially place semaglutide on the lists.

article thumbnail

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

Pharmacy Times

Pharmacists can leverage patient medical history for formulating effective drugs, and patients can also benefit from single dosage, greater efficacy, and affordability of compounded medications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages

Drug Topics

Novo Nordisk is the only company with FDA-approved products containing semaglutide.

article thumbnail

Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop

Pharmacy Times

The workshop addressed trends, initiatives, and regulations for quality compounding.

article thumbnail

Opinion: The FDA’s risky action on compounding weight loss drugs

STAT

Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.

article thumbnail

Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list

Fierce Pharma

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.”

article thumbnail

FDA issues warnings to GLP-1 compounders

The Checkup by Singlecare

As a result, the use of medications like Ozempic , Wegovy , Zepbound , Rybelsus , and Mounjaro has skyrocketed, as people turned to these medications to help them lose weightcausing drug shortages and creating a market for compounded versions of these brand-name drugs. RELATED: Is compounded semaglutide safe? But the U.S.